http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I234585-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_079e4a351e03146e8b7a5afc3975d086 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate | 2002-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cc1b160f26b3451a480d8e16ec826c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705f43fe0e6e66825f24b242f63ba083 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8ab3d60528d286b0175a47d07e0183f |
publicationDate | 2005-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-I234585-B |
titleOfInvention | HURP gene as a molecular marker for bladder cancer |
abstract | Hepatoma up-regulated protein (HURP) gene serves as a useful molecular marker in the detection, preliminary screening and monitoring of bladder cancer in a human subject. A method for the detection of bladder cancer, in particular transitional cell carcinoma (TCC) of the bladder, in a human subject is disclosed, in which the detected expression of the human HURP gene in a sample taken from a subject suspected to have bladder cancer is indicative of the presence of the bladder cancer. The present invention further provides a non-invasive method for the detection, preliminary screening or monitoring of urinary TCC in a suspected subject, in which a urine sample taken from the subject is analyzed to determine an expression of the human HURP gene, the presence of which is indicative of the presence of urinary TCC. |
priorityDate | 2002-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.